Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Pre Earnings
TOI - Stock Analysis
4606 Comments
1452 Likes
1
Princeelijah
Community Member
2 hours ago
Pure excellence, served on a silver platter. 🍽️
👍 23
Reply
2
Jacci
Returning User
5 hours ago
This gave me confidence I absolutely don’t deserve.
👍 280
Reply
3
Omarri
Expert Member
1 day ago
This feels like a loop.
👍 174
Reply
4
Asadbek
Loyal User
1 day ago
You make multitasking look like a magic trick. 🎩✨
👍 59
Reply
5
Issiah
Engaged Reader
2 days ago
Absolutely smashing it today! 💥
👍 112
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.